IRCT20210915052492N1已完成3 期
Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: A placebo-controlled, triple-blind, randomized trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with cancer and malignant pleural effusion
- •Chest tube discharge>150 cc/day
- •Estimated survival>6 months
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Continuous subcutaneous injection of octreotide for congtenital hyperinsulinism: efficacy and safety.congenital hyperinsulinismJPRN-UMIN000012620Japan Agency for Medical Research and Development. Research group for the study on "Efficacy and safety of subcutaneous continuous octreotide infusion for congenital hyperinsulinism."7
进行中（未招募）
1 期
TILT - a trial of a bacterial agent called OK432, administered directly into the chest via an indwelling catheter in people with cancer of the lung lining (mesothelioma).MedDRA version: 20.0Level: PTClassification code 10059518Term: Pleural mesothelioma malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Malignant pleural mesotheliomaEUCTR2016-004727-23-GBorth Bristol NHS Trust Research & Innovation45
尚未招募
2 期
PeRsOnalized treatment fOr patients with pleural eFfusions due to malignant pleural mesothelioma or lung cancer in second or third line. An open label phase II study (Acronym: the PROOF study)mesothelioma and lungcancer10038666NL-OMON40679Antoni van Leeuwenhoek Ziekenhuis80
进行中（未招募）
不适用
Personalized treatment for patients with pleural effusionsEUCTR2013-005621-24-NLStichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis
招募中
不适用
Sono-guided prolotherapy/ oxygen-ozone/ corticosteroid therapy for the treatment of musculoskeletal pain in physical and rehabilitation medicine: Interventional pain management for trochanteric bursitis: a prospective, randomized, double-blind, positive control, multicenter clinical trial.IRCT20100827004641N16Iran university of medical sciences48